Literature DB >> 8242743

Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor.

P Franzén1, P ten Dijke, H Ichijo, H Yamashita, P Schulz, C H Heldin, K Miyazono.   

Abstract

A cDNA clone encoding a 53 kd serine/threonine kinase receptor with an overall structure similar to that of the type II receptor for transforming growth factor beta (TGF beta) was obtained. 125I-TGF beta 1 bound to porcine endothelial cells transfected with the cDNA and formed a cross-linked complex of 70 kd, characteristic of a TGF beta type I receptor. Immunoprecipitation of the cross-linked complexes by antibodies against the cloned receptor revealed the 70 kd complex as well as a 94 kd TGF beta type II receptor complex. The immunoprecipitated novel serine/threonine kinase receptor had biochemical properties of the TGF beta type I receptor and was observed in different cell types. Transfection of the cloned cDNA into TGF beta type I receptor-deficient cells restored TGF beta-induced plasminogen activator inhibitor 1 production. These results suggest that signal transduction by TGF beta involves the formation of a heteromeric complex of two different serine/threonine kinase receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8242743     DOI: 10.1016/0092-8674(93)90489-d

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  128 in total

1.  Repeat cDNA synthesis and RT-PCR with the same source of RNA.

Authors:  B Fuchs; K Zhang; M G Rock; M E Bolander; G Sarkar
Journal:  Mol Biotechnol       Date:  1999-10       Impact factor: 2.695

2.  TGF-beta in mammary development and neoplasia.

Authors:  C L Arteaga; H L Moses
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-10       Impact factor: 2.673

3.  Differentiated intestinal epithelial cells express high levels of TGF-β receptors and exhibit increased sensitivity to growth inhibition.

Authors:  Navneeta Rathor; Shelley R Wang; Elizabeth T Chang; Jaladanki N Rao
Journal:  Int J Clin Exp Med       Date:  2011-11-10

4.  Coated pit-mediated endocytosis of the type I transforming growth factor-β (TGF-β) receptor depends on a di-leucine family signal and is not required for signaling.

Authors:  Keren E Shapira; Avner Gross; Marcelo Ehrlich; Yoav I Henis
Journal:  J Biol Chem       Date:  2012-06-15       Impact factor: 5.157

5.  Endoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation.

Authors:  Melania E Mercado-Pimentel; Antony D Hubbard; Raymond B Runyan
Journal:  Dev Biol       Date:  2006-12-23       Impact factor: 3.582

Review 6.  GDF-9 and BMP-15 direct the follicle symphony.

Authors:  Alexandra Sanfins; Patrícia Rodrigues; David F Albertini
Journal:  J Assist Reprod Genet       Date:  2018-07-23       Impact factor: 3.412

7.  Cloning and characterization of a human type II receptor for bone morphogenetic proteins.

Authors:  B L Rosenzweig; T Imamura; T Okadome; G N Cox; H Yamashita; P ten Dijke; C H Heldin; K Miyazono
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

8.  Characterization of a human hepatoma cell line with acquired resistance to growth inhibition by transforming growth factor beta 1 (TGF-beta 1).

Authors:  K Hasegawa; Z Wang; M Inagaki; B I Carr
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-01       Impact factor: 2.416

9.  Different domains regulate homomeric and heteromeric complex formation among type I and type II transforming growth factor-beta receptors.

Authors:  Maya Mouler Rechtman; Alex Nakaryakov; Keren E Shapira; Marcelo Ehrlich; Yoav I Henis
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

10.  Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies.

Authors:  F L Hall; P D Benya; S R Padilla; D Carbonaro-Hall; R Williams; S Buckley; D Warburton
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.